Journal
PHARMACEUTICALS
Volume 12, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/ph12020052
Keywords
dotatate; drugs; inotersen; Lutathera; oligonucleotides; Onpattro; patisiran; peptides; pharmaceutical market; Tegsedi
Categories
Funding
- University of KwaZulu-Natal (South Africa)
- Spanish Ministry of Economy, Industry and Competitiveness (MINECO) [CTQ2015-67870-P]
- Generalitat de Catalunya (Spain) [2017 SGR 1439]
- National Research Foundation (NRF) (CSUR) [105892]
- National Research Foundation (NRF) (Blue Sky's Research Programme) [110960]
Ask authors/readers for more resources
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
